Gene	Variant_Classification	Alteration	Tumor_allele	Reference_allele	dbSNP_RS	bin	Score_bin	Chromosome	Start_position	End_position	Coverage	Allelic_fraction	Number_of_Probes	Segment_Mean	In_Segment	Pathways	COSMIC_overlapping_mutations	COSMIC_total_alterations_in_gene	UniProt_Region	Rationale	Tumor_Sample_Barcode	Clinical_trials	mutation.assessor
BRAF	Missense_Mutation	p.V600E	A	A	rs121913377|rs113488022|rs121913227|rs397516897	-0.25	Actionable	7	140453136	140453136	718	0.639275766016713	NA	NA	NA		p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	27380	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Mutations predict sensitivity to RAF inhibitors. Amplification may predict resistance to MEK inhibitors.	MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRAF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,140453136,A,A&fts=all">p.V600E</a>
CDKN2A	Copy Number	Deleted	NA	NA	NA	0	Investigate Actionability	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA	Biallelic inactivation may predict sensitivity to CDK4/6 inhibitors.	MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKN2A&recr=Open">Click here</a>	
CDKN2B	Copy Number	Deleted	NA	NA	NA	0	Investigate Actionability	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA	Biallelic inactivation may predict sensitivity to CDK4/6 inhibitors.	MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKN2B&recr=Open">Click here</a>	
AR	Missense_Mutation	p.D545N	G	G		2	High Priority	X	66863114	66863114	106	0.716981132075472	NA	NA	NA			67	Modulating.	Amplification may predict resistance to androgen deprivation in prostate cancer and may predict sensitivity to second generation androgen deprivation or direct androgen inhibitors	MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,66863114,G,G&fts=all">p.D545N</a>
MLLT4	Missense_Mutation	p.V572G	T	T		4	Cancer Gene Census	6	168307915	168307915	143	0.594405594405594	NA	NA	NA			65			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLLT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,168307915,T,T&fts=all">p.V572G</a>
FGF6	Missense_Mutation	p.G178E	C	C		4.125	Cancer Pathway Linked to: BRAF; AR; CDKN2A; CDKN2B	12	4543475	4543475	115	0.417391304347826	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		20			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,4543475,C,C&fts=all">p.G178E</a>
PSMD11	Missense_Mutation	p.L165F	C	C		5	Cancer Pathway	17	30796061	30796061	169	0.272189349112426	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		19			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSMD11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,30796061,C,C&fts=all">p.L165F</a>
STAT4	Missense_Mutation	p.M407I	C	C		5	Cancer Pathway	2	191919246	191919246	490	0.373469387755102	NA	NA	NA	 BIOCARTA_EGF_PATHWAY  | 		42			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,191919246,C,C&fts=all">p.M407I</a>
BZRAP1	Missense_Mutation	p.F684Y	A	A		7	Cancer Module	17	56389951	56389951	64	0.28125	NA	NA	NA			54	SH3 1. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BZRAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56389951,A,A&fts=all">p.F684Y</a>
CACNA1A	Missense_Mutation	p.T1075I	G	G		7	Cancer Module	19	13397646	13397646	17	0.352941176470588	NA	NA	NA			42			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,13397646,G,G&fts=all">p.T1075I</a>
CNTN2	Missense_Mutation	p.V824I	G	G		7	Cancer Module	1	205039592	205039592	24	0.291666666666667	NA	NA	NA			54	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,205039592,G,G&fts=all">p.V824I</a>
CRYGC	Nonsense_Mutation	p.Q149*	G	G	rs555354568	7	Cancer Module	2	208993007	208993007	244	0.434426229508197	NA	NA	NA			9	Beta/gamma crystallin 'Greek key' 4. {ECO:0000255|PROSITE-ProRule:PRU00028}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYGC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,208993007,G,G&fts=all">p.Q149*</a>
DDX17	Splice_Site	p.P179P	T	T		7	Cancer Module	22	38895406	38895406	173	0.115606936416185	NA	NA	NA			25			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX17&recr=Open">Click here</a>	
DENND3	Missense_Mutation	p.T949M	C	C	rs143673786	7	Cancer Module	8	142190855	142190855	75	0.0533333333333333	NA	NA	NA			55			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DENND3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,142190855,C,C&fts=all">p.T949M</a>
DNAH5	Frame_Shift_Del	p.K3058fs	T	T		7	Cancer Module	5	13776747	13776747	287	0.209059233449477	NA	NA	NA			378	AAA 4. {ECO:0000250}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DSCR4	Missense_Mutation	p.Y93C	T	T		7	Cancer Module	21	39427028	39427028	146	0.136986301369863	NA	NA	NA			6			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,39427028,T,T&fts=all">p.Y93C</a>
DSP	Missense_Mutation	p.E1345K	G	G		7	Cancer Module	6	7580456	7580456	124	0.532258064516129	NA	NA	NA			101	Central fibrous rod domain.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,7580456,G,G&fts=all">p.E1345K</a>
ECHS1	Missense_Mutation	p.S199L	G	G		7	Cancer Module	10	135180416	135180416	28	0.571428571428571	NA	NA	NA			10			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECHS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,135180416,G,G&fts=all">p.S199L</a>
EVPL	Missense_Mutation	p.R555C	G	G		7	Cancer Module	17	74013867	74013867	40	0.225	NA	NA	NA			54	Globular 1.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVPL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,74013867,G,G&fts=all">p.R555C</a>
FSTL4	Missense_Mutation	p.E86K	C	C	rs150349571	7	Cancer Module	5	132736583	132736583	22	0.181818181818182	NA	NA	NA			23	Kazal-like. {ECO:0000255|PROSITE- ProRule:PRU00798}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSTL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,132736583,C,C&fts=all">p.E86K</a>
HCLS1	Missense_Mutation	p.R93Q	C	C		7	Cancer Module	3	121366176	121366176	715	0.332867132867133	NA	NA	NA		p.R93Q(1)	35			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCLS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,121366176,C,C&fts=all">p.R93Q</a>
IFNA1	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA1&recr=Open">Click here</a>	
IFNA13	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA13&recr=Open">Click here</a>	
IFNA2	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA2&recr=Open">Click here</a>	
IFNA21	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA21&recr=Open">Click here</a>	
IFNA4	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA4&recr=Open">Click here</a>	
IFNA5	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA5&recr=Open">Click here</a>	
KIF13A	Missense_Mutation	p.Q630K	G	G		7	Cancer Module	6	17817363	17817363	193	0.0829015544041451	NA	NA	NA			64			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF13A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,17817363,G,G&fts=all">p.Q630K</a>
MAZ	Missense_Mutation	p.H419L	A	A		7	Cancer Module	16	29820039	29820039	34	0.382352941176471	NA	NA	NA			10			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAZ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,29820039,A,A&fts=all">p.H419L</a>
MUC16	Missense_Mutation	p.P7738L	G	G	rs373045584	7	Cancer Module	19	9064233	9064233	141	0.361702127659574	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9064233,G,G&fts=all">p.P7738L</a>
MUSK	Nonsense_Mutation	p.W524*	G	G		7	Cancer Module	9	113547282	113547282	323	0.303405572755418	NA	NA	NA			49			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUSK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,113547282,G,G&fts=all">p.W524*</a>
MYO15A	Missense_Mutation	p.A1751S	G	G		7	Cancer Module	17	18043870	18043870	92	0.369565217391304	NA	NA	NA			99	Myosin motor.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO15A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,18043870,G,G&fts=all">p.A1751S</a>
MYO5A	Missense_Mutation	p.R1615W	G	G		7	Cancer Module	15	52613589	52613589	197	0.0203045685279188	NA	NA	NA			57	Dilute. {ECO:0000255|PROSITE- ProRule:PRU00503}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,52613589,G,G&fts=all">p.R1615W</a>
NUP133	Missense_Mutation	p.V1025I	C	C		7	Cancer Module	1	229588298	229588298	400	0.435	NA	NA	NA			56			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP133&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,229588298,C,C&fts=all">p.V1025I</a>
PARD3	Missense_Mutation	p.R1030Q	C	C		7	Cancer Module	10	34573159	34573159	257	0.0155642023346304	NA	NA	NA			63	Lys-rich.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,34573159,C,C&fts=all">p.R1030Q</a>
PNMT	Splice_Site	p.G39G	G	G		7	Cancer Module	17	37826204	37826204	34	0.411764705882353	NA	NA	NA			8			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNMT&recr=Open">Click here</a>	
POSTN	Missense_Mutation	p.G401E	C	C		7	Cancer Module	13	38158147	38158147	218	0.36697247706422	NA	NA	NA			59	FAS1 3. {ECO:0000255|PROSITE- ProRule:PRU00082, ECO:0000305}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POSTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,38158147,C,C&fts=all">p.G401E</a>
PRKAB2	Missense_Mutation	p.A195V	G	G	rs587771645	7	Cancer Module	1	146634107	146634107	209	0.062200956937799	NA	NA	NA			11			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKAB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,146634107,G,G&fts=all">p.A195V</a>
PTPN13	Missense_Mutation	p.S1310F	C	C		7	Cancer Module	4	87684255	87684255	407	0.316953316953317	NA	NA	NA			93			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,87684255,C,C&fts=all">p.S1310F</a>
PTPRD	Missense_Mutation	p.S1082L	G	G		7	Cancer Module	9	8484287	8484287	100	0.48	NA	NA	NA			168	Fibronectin type-III 8. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,8484287,G,G&fts=all">p.S1082L</a>
PTPRD	Missense_Mutation	p.E558K	C	C		7	Cancer Module	9	8507306	8507306	265	0.539622641509434	NA	NA	NA			168	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,8507306,C,C&fts=all">p.E558K</a>
PTPRH	Missense_Mutation	p.E750K	C	C	rs145253735	7	Cancer Module	19	55707899	55707899	52	0.384615384615385	NA	NA	NA			67			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55707899,C,C&fts=all">p.E750K</a>
RIMS2	Missense_Mutation	p.D307N	G	G		7	Cancer Module	8	104898412	104898412	283	0.438162544169611	NA	NA	NA			144			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,104898412,G,G&fts=all">p.D307N</a>
SAGE1	Missense_Mutation	p.T365I	C	C		7	Cancer Module	X	134989935	134989935	168	0.708333333333333	NA	NA	NA			55			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAGE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,134989935,C,C&fts=all">p.T365I</a>
SEMA6B	Missense_Mutation	p.G238C	C	C		7	Cancer Module	19	4554459	4554459	35	0.314285714285714	NA	NA	NA			21	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4554459,C,C&fts=all">p.G238C</a>
SEMA6B	Nonsense_Mutation	p.W237*	C	C		7	Cancer Module	19	4554460	4554460	35	0.314285714285714	NA	NA	NA			21	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4554460,C,C&fts=all">p.W237*</a>
SIGLEC5	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	19	52133471	52150014	NA	NA	9	-2.14178023372893	FALSE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC5&recr=Open">Click here</a>	
SLC5A2	Missense_Mutation	p.D158N	G	G		7	Cancer Module	16	31497494	31497494	56	0.392857142857143	NA	NA	NA			25			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,31497494,G,G&fts=all">p.D158N</a>
SLCO2B1	Missense_Mutation	p.S297F	C	C		7	Cancer Module	11	74911324	74911324	64	0.421875	NA	NA	NA			39			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO2B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,74911324,C,C&fts=all">p.S297F</a>
SLIT2	Missense_Mutation	p.R1294C	C	C		7	Cancer Module	4	20618565	20618565	112	0.0446428571428571	NA	NA	NA			116	Laminin G-like. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,20618565,C,C&fts=all">p.R1294C</a>
SMR3B	Missense_Mutation	p.P34L	C	C		7	Cancer Module	4	71255426	71255426	163	0.0613496932515337	NA	NA	NA			7	Pro-rich.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMR3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71255426,C,C&fts=all">p.P34L</a>
SOX9	Missense_Mutation	p.K398N	G	G		7	Cancer Module	17	70120192	70120192	71	0.0985915492957746	NA	NA	NA			26			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOX9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,70120192,G,G&fts=all">p.K398N</a>
TBX2	Missense_Mutation	p.P591L	C	C		7	Cancer Module	17	59485500	59485500	20	0.45	NA	NA	NA			9	Ala-rich.|Repression domain 1 (RD1).		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,59485500,C,C&fts=all">p.P591L</a>
TTN	Missense_Mutation	p.E10845K	C	C		7	Cancer Module	2	179549654	179549654	130	0.353846153846154	NA	NA	NA			1448	Glu-rich.|Pro-rich.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179549654,C,C&fts=all">p.E10845K</a>
USH2A	Missense_Mutation	p.R1295Q	C	C	rs372993160	7	Cancer Module	1	216371854	216371854	437	0.28604118993135	NA	NA	NA			527	Fibronectin type-III 3. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,216371854,C,C&fts=all">p.R1295Q</a>
ZNF107	Missense_Mutation	p.N566H	A	A		7	Cancer Module	7	64168378	64168378	907	0.00771775082690187	NA	NA	NA			37			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF107&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,64168378,A,A&fts=all">p.N566H</a>
ZNF264	Missense_Mutation	p.S553F	C	C		7	Cancer Module	19	57724123	57724123	174	0.379310344827586	NA	NA	NA			27			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF264&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57724123,C,C&fts=all">p.S553F</a>
ZRANB2	Missense_Mutation	p.A26G	G	G		7	Cancer Module	1	71544371	71544371	623	0.043338683788122	NA	NA	NA			15			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZRANB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,71544371,G,G&fts=all">p.A26G</a>
ACOXL	Missense_Mutation	p.G516R	G	G		8	Cancer Gene	2	111850457	111850457	556	0.33273381294964	NA	NA	NA			21			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACOXL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,111850457,G,G&fts=all">p.G516R</a>
AFF2	Missense_Mutation	p.H795Y	C	C		8	Cancer Gene	X	148037958	148037958	100	0.72	NA	NA	NA			109			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,148037958,C,C&fts=all">p.H795Y</a>
ARHGAP21	Missense_Mutation	p.H1270Y	G	G		8	Cancer Gene	10	24883947	24883947	200	0.52	NA	NA	NA			78	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,24883947,G,G&fts=all">p.H1270Y</a>
ASTN1	Missense_Mutation	p.D1083N	C	C		8	Cancer Gene	1	176852110	176852110	125	0.24	NA	NA	NA			153	Fibronectin type-III 1.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176852110,C,C&fts=all">p.D1083N</a>
C10orf71	Missense_Mutation	p.D34N	G	G		8	Cancer Gene	10	50530690	50530690	14	0.428571428571429	NA	NA	NA			1			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf71&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,50530690,G,G&fts=all">p.D34N</a>
CCDC60	Missense_Mutation	p.L425F	C	C		8	Cancer Gene	12	119966463	119966463	262	0.435114503816794	NA	NA	NA			40			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC60&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,119966463,C,C&fts=all">p.L425F</a>
CEP128	Missense_Mutation	p.R954H	C	C		8	Cancer Gene	14	81025642	81025642	329	0.0151975683890578	NA	NA	NA			51			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP128&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,81025642,C,C&fts=all">p.R954H</a>
CEP164	Missense_Mutation	p.L1301V	C	C		8	Cancer Gene	11	117280486	117280486	92	0.0652173913043478	NA	NA	NA			47			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP164&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,117280486,C,C&fts=all">p.L1301V</a>
CES3	Missense_Mutation	p.G184D	G	G	rs533016051	8	Cancer Gene	16	66997829	66997829	42	0.404761904761905	NA	NA	NA			24			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CES3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,66997829,G,G&fts=all">p.G184D</a>
CHST8	Missense_Mutation	p.R263K	G	G		8	Cancer Gene	19	34263481	34263481	44	0.431818181818182	NA	NA	NA			27			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHST8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,34263481,G,G&fts=all">p.R263K</a>
CRISPLD1	Missense_Mutation	p.A216V	C	C		8	Cancer Gene	8	75927067	75927067	299	0.0133779264214047	NA	NA	NA			43			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRISPLD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,75927067,C,C&fts=all">p.A216V</a>
CSMD1	Splice_Site	p.V1801I	C	C		8	Cancer Gene	8	3047434	3047434	10	0.4	NA	NA	NA			25	Sushi 10. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	
CYP2A13	Missense_Mutation	p.E277K	G	G		8	Cancer Gene	19	41597811	41597811	49	0.26530612244898	NA	NA	NA			42			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2A13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,41597811,G,G&fts=all">p.E277K</a>
DEPTOR	Splice_Site	p.T332M	C	C		8	Cancer Gene	8	121019113	121019113	162	0.148148148148148	NA	NA	NA			18	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEPTOR&recr=Open">Click here</a>	
DMRTA1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	FALSE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMRTA1&recr=Open">Click here</a>	
EML5	Missense_Mutation	p.P826S	G	G		8	Cancer Gene	14	89160714	89160714	58	0.172413793103448	NA	NA	NA			50			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EML5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,89160714,G,G&fts=all">p.P826S</a>
ERCC6L	Missense_Mutation	p.E586A	T	T		8	Cancer Gene	X	71426491	71426491	135	0.140740740740741	NA	NA	NA			38	Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC6L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,71426491,T,T&fts=all">p.E586A</a>
FAM22A	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	10	88985969	88993346	NA	NA	5	-1.06340917017606	FALSE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM22A&recr=Open">Click here</a>	
FAM24A	Missense_Mutation	p.S28G	A	A		8	Cancer Gene	10	124671232	124671232	340	0.561764705882353	NA	NA	NA			9			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM24A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124671232,A,A&fts=all">p.S28G</a>
FLG	Missense_Mutation	p.S952R	A	A		8	Cancer Gene	1	152284506	152284506	390	0.143589743589744	NA	NA	NA			424	Ser-rich.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152284506,A,A&fts=all">p.S952R</a>
FN3KRP	Missense_Mutation	p.V165A	T	T		8	Cancer Gene	17	80684381	80684381	148	0.0337837837837838	NA	NA	NA			7			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FN3KRP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,80684381,T,T&fts=all">p.V165A</a>
FRAS1	Missense_Mutation	p.R124Q	G	G	rs200764508	8	Cancer Gene	4	79173607	79173607	252	0.0158730158730159	NA	NA	NA		p.R124Q(3)	103	VWFC 2. {ECO:0000255|PROSITE- ProRule:PRU00220}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRAS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,79173607,G,G&fts=all">p.R124Q</a>
GPBP1L1	Missense_Mutation	p.A166T	C	C		8	Cancer Gene	1	46108153	46108153	414	0.654589371980676	NA	NA	NA			21			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPBP1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,46108153,C,C&fts=all">p.A166T</a>
GPX6	Missense_Mutation	p.G148E	C	C		8	Cancer Gene	6	28472192	28472192	210	0.238095238095238	NA	NA	NA			19			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPX6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28472192,C,C&fts=all">p.G148E</a>
GRID2	Missense_Mutation	p.G503E	G	G		8	Cancer Gene	4	94344082	94344082	127	0.566929133858268	NA	NA	NA			100			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,94344082,G,G&fts=all">p.G503E</a>
HDAC7	Missense_Mutation	p.G799R	C	C		8	Cancer Gene	12	48180428	48180428	21	0.142857142857143	NA	NA	NA			25	Histone deacetylase.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HDAC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,48180428,C,C&fts=all">p.G799R</a>
HSF5	Missense_Mutation	p.R31C	G	G		8	Cancer Gene	17	56565545	56565545	38	0.368421052631579	NA	NA	NA			16			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSF5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56565545,G,G&fts=all">p.R31C</a>
IFNA10	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA10&recr=Open">Click here</a>	
IFNA14	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA14&recr=Open">Click here</a>	
IFNA16	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA16&recr=Open">Click here</a>	
IFNA17	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA17&recr=Open">Click here</a>	
IFNA6	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA6&recr=Open">Click here</a>	
IFNA7	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA7&recr=Open">Click here</a>	
IFNA8	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA8&recr=Open">Click here</a>	
IFNB1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	FALSE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNB1&recr=Open">Click here</a>	
IFNE	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNE&recr=Open">Click here</a>	
IFNW1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNW1&recr=Open">Click here</a>	
KIF13B	Missense_Mutation	p.L1443F	G	G		8	Cancer Gene	8	28950393	28950393	75	0.346666666666667	NA	NA	NA			28			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF13B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,28950393,G,G&fts=all">p.L1443F</a>
KLF2	Missense_Mutation	p.T327M	C	C		8	Cancer Gene	19	16437754	16437754	32	0.09375	NA	NA	NA			5			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,16437754,C,C&fts=all">p.T327M</a>
KLHL9	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL9&recr=Open">Click here</a>	
LGALS12	Missense_Mutation	p.G26R	G	G		8	Cancer Gene	11	63273940	63273940	99	0.303030303030303	NA	NA	NA			16			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGALS12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,63273940,G,G&fts=all">p.G26R</a>
MTAP	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTAP&recr=Open">Click here</a>	
MTUS2	Missense_Mutation	p.E302K	G	G		8	Cancer Gene	13	29599709	29599709	25	0.4	NA	NA	NA			20			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTUS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,29599709,G,G&fts=all">p.E302K</a>
NBAS	Missense_Mutation	p.P2196L	G	G		8	Cancer Gene	2	15326990	15326990	342	0.388888888888889	NA	NA	NA			112			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NBAS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,15326990,G,G&fts=all">p.P2196L</a>
OR10X1	Missense_Mutation	p.H267Y	G	G		8	Cancer Gene	1	158548891	158548891	365	0.298630136986301	NA	NA	NA			37			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10X1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158548891,G,G&fts=all">p.H267Y</a>
OR4A16	Missense_Mutation	p.G39E	G	G	rs267602960	8	Cancer Gene	11	55110792	55110792	276	0.253623188405797	NA	NA	NA		p.G39V(1)	51			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4A16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,55110792,G,G&fts=all">p.G39E</a>
OR4D10	Missense_Mutation	p.R89K	G	G		8	Cancer Gene	11	59245168	59245168	204	0.338235294117647	NA	NA	NA			30			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4D10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,59245168,G,G&fts=all">p.R89K</a>
OR51V1	Missense_Mutation	p.I113N	A	A		8	Cancer Gene	11	5221593	5221593	92	0.282608695652174	NA	NA	NA			39			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51V1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5221593,A,A&fts=all">p.I113N</a>
OR5K4	Missense_Mutation	p.R53C	C	C	rs201921508	8	Cancer Gene	3	98072854	98072854	1056	0.136363636363636	NA	NA	NA			21			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5K4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,98072854,C,C&fts=all">p.R53C</a>
PROKR2	Missense_Mutation	p.S355F	G	G		8	Cancer Gene	20	5282777	5282777	91	0.340659340659341	NA	NA	NA			53			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROKR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,5282777,G,G&fts=all">p.S355F</a>
RNF219	Missense_Mutation	p.T132I	G	G		8	Cancer Gene	13	79213112	79213112	459	0.302832244008715	NA	NA	NA			32			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF219&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,79213112,G,G&fts=all">p.T132I</a>
ROBO2	Missense_Mutation	p.D271N	G	G		8	Cancer Gene	3	77571930	77571930	678	0.309734513274336	NA	NA	NA			117	Ig-like C2-type 3.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROBO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,77571930,G,G&fts=all">p.D271N</a>
SCN10A	Missense_Mutation	p.E1381K	C	C		8	Cancer Gene	3	38752337	38752337	28	0.321428571428571	NA	NA	NA			150			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN10A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38752337,C,C&fts=all">p.E1381K</a>
SIGLEC14	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	19	52133471	52150014	NA	NA	9	-2.14178023372893	FALSE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC14&recr=Open">Click here</a>	
SLC24A2	Missense_Mutation	p.E265K	C	C		8	Cancer Gene	9	19786072	19786072	154	0.564935064935065	NA	NA	NA			33			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC24A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,19786072,C,C&fts=all">p.E265K</a>
SLC7A14	Missense_Mutation	p.S591L	G	G		8	Cancer Gene	3	170198299	170198299	64	0.375	NA	NA	NA			53			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,170198299,G,G&fts=all">p.S591L</a>
SLITRK6	Missense_Mutation	p.S406L	G	G		8	Cancer Gene	13	86369427	86369427	311	0.308681672025723	NA	NA	NA			51			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,86369427,G,G&fts=all">p.S406L</a>
ST6GAL2	Missense_Mutation	p.R11Q	C	C		8	Cancer Gene	2	107460402	107460402	38	0.394736842105263	NA	NA	NA		p.R11Q(1)	65			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST6GAL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,107460402,C,C&fts=all">p.R11Q</a>
SUPT6H	Missense_Mutation	p.E382K	G	G	rs536803388	8	Cancer Gene	17	27005590	27005590	105	0.285714285714286	NA	NA	NA			64	Interaction with IWS1. {ECO:0000250}.|Interaction with KDM6A. {ECO:0000250}.|Interaction with PAAF1.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUPT6H&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,27005590,G,G&fts=all">p.E382K</a>
TRERF1	Missense_Mutation	p.P991L	G	G		8	Cancer Gene	6	42204037	42204037	22	0.227272727272727	NA	NA	NA			45	Interacts with CREBBP.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRERF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,42204037,G,G&fts=all">p.P991L</a>
TXNRD1	Missense_Mutation	p.A415V	C	C		8	Cancer Gene	12	104732978	104732978	76	0.0526315789473684	NA	NA	NA			16			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TXNRD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104732978,C,C&fts=all">p.A415V</a>
USH1C	Missense_Mutation	p.S144F	G	G		8	Cancer Gene	11	17548835	17548835	79	0.316455696202532	NA	NA	NA			48	PDZ 1. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,17548835,G,G&fts=all">p.S144F</a>
VPS13A	Missense_Mutation	p.H1948Y	C	C		8	Cancer Gene	9	79937994	79937994	158	0.39873417721519	NA	NA	NA			104			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,79937994,C,C&fts=all">p.H1948Y</a>
YTHDC1	Missense_Mutation	p.R719Q	C	C	rs368902802	8	Cancer Gene	4	69179845	69179845	229	0.0349344978165939	NA	NA	NA		p.R719Q(1)	30	Arg-rich.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YTHDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,69179845,C,C&fts=all">p.R719Q</a>
C9orf53	Copy Number	Deleted	NA	NA	NA	9	VUS	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9orf53&recr=Open">Click here</a>	
CDKN2BAS	Copy Number	Deleted	NA	NA	NA	9	VUS	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKN2BAS&recr=Open">Click here</a>	
LOC554202	Copy Number	Deleted	NA	NA	NA	9	VUS	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LOC554202&recr=Open">Click here</a>	
LOC728190	Copy Number	Deleted	NA	NA	NA	9	VUS	10	88985969	88993346	NA	NA	5	-1.06340917017606	FALSE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LOC728190&recr=Open">Click here</a>	
MIR31	Copy Number	Deleted	NA	NA	NA	9	VUS	9	21077870	22451912	NA	NA	31	-1.62015727250832	TRUE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR31&recr=Open">Click here</a>	
MIR548H2	Copy Number	Deleted	NA	NA	NA	9	VUS	9	21077870	22451912	NA	NA	31	-1.62015727250832	FALSE		NA	NA	NA		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR548H2&recr=Open">Click here</a>	
BRINP3	Missense_Mutation	p.L473F	G	G		10	SNP	1	190068032	190068032	383	0.140992167101828	NA	NA	NA						MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,190068032,G,G&fts=all">p.L473F</a>
DHRS7C	Missense_Mutation	p.R266Q	C	C		10	SNP	17	9674944	9674944	14	0.357142857142857	NA	NA	NA			15			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHRS7C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,9674944,C,C&fts=all">p.R266Q</a>
FAM71F2	Missense_Mutation	p.P219L	C	C		10	SNP	7	128320125	128320125	16	0.75	NA	NA	NA			7			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM71F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,128320125,C,C&fts=all">p.P219L</a>
TENM3	Missense_Mutation	p.T1401A	A	A		10	SNP	4	183675721	183675721	47	0.234042553191489	NA	NA	NA						MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,183675721,A,A&fts=all">p.T1401A</a>
ACSM2A	Intron		C	C		11	Filtered Calls	16	20482846	20482846	259	0.32046332046332	NA	NA	NA			51			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSM2A&recr=Open">Click here</a>	
AFF4	Intron		C	C		11	Filtered Calls	5	132224768	132224768	376	0.164893617021277	NA	NA	NA			43			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFF4&recr=Open">Click here</a>	
AGXT2	Silent	p.H120H	G	G		11	Filtered Calls	5	35039431	35039431	439	0.355353075170843	NA	NA	NA			41			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGXT2&recr=Open">Click here</a>	
ANAPC5	Silent	p.Y302Y	G	G	rs140257918	11	Filtered Calls	12	121773380	121773380	519	0.00963391136801541	NA	NA	NA			31			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANAPC5&recr=Open">Click here</a>	
ATG16L2	Intron		T	T		11	Filtered Calls	11	72539974	72539974	81	0.432098765432099	NA	NA	NA			14			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATG16L2&recr=Open">Click here</a>	
ATP2B2	Silent	p.I1071I	G	G	rs534428399	11	Filtered Calls	3	10379932	10379932	30	0.366666666666667	NA	NA	NA			74			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP2B2&recr=Open">Click here</a>	
C14orf166B	Intron		C	C		11	Filtered Calls	14	77323713	77323713	19	0.421052631578947	NA	NA	NA			18			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C14orf166B&recr=Open">Click here</a>	
C15orf60	Silent	p.L82L	A	A		11	Filtered Calls	15	73766259	73766259	68	0.294117647058824	NA	NA	NA			17			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C15orf60&recr=Open">Click here</a>	
C1R	5'Flank		C	C		11	Filtered Calls	12	7242021	7242021	20	0.35	NA	NA	NA			16			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1R&recr=Open">Click here</a>	
C1S	Intron		C	C		11	Filtered Calls	12	7169889	7169889	245	0.371428571428571	NA	NA	NA			33			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1S&recr=Open">Click here</a>	
C9	Silent	p.N198N	G	G		11	Filtered Calls	5	39331799	39331799	305	0.377049180327869	NA	NA	NA			32	MACPF. {ECO:0000255|PROSITE- ProRule:PRU00745}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9&recr=Open">Click here</a>	
CASKIN1	Silent	p.I260I	G	G		11	Filtered Calls	16	2237222	2237222	23	0.304347826086957	NA	NA	NA			28			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASKIN1&recr=Open">Click here</a>	
CCDC40	Silent	p.I227I	C	C		11	Filtered Calls	17	78022386	78022386	35	0.228571428571429	NA	NA	NA			38			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC40&recr=Open">Click here</a>	
CCDC88C	Silent	p.S1503S	G	G		11	Filtered Calls	14	91749794	91749794	19	0.263157894736842	NA	NA	NA			24			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC88C&recr=Open">Click here</a>	
CD5L	Intron		T	T		11	Filtered Calls	1	157805613	157805613	161	0.0434782608695652	NA	NA	NA			52			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD5L&recr=Open">Click here</a>	
CDH18	Silent	p.L479L	C	C		11	Filtered Calls	5	19520841	19520841	380	0.360526315789474	NA	NA	NA		p.L479L(2)	138	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH18&recr=Open">Click here</a>	
CER1	Silent	p.F105F	G	G	rs566653762	11	Filtered Calls	9	14722356	14722356	68	0.544117647058823	NA	NA	NA			11			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CER1&recr=Open">Click here</a>	
CNTN2	Silent	p.I428I	C	C		11	Filtered Calls	1	205033493	205033493	246	0.333333333333333	NA	NA	NA			54	Ig-like C2-type 5.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTN2&recr=Open">Click here</a>	
COL13A1	Intron		C	C		11	Filtered Calls	10	71681630	71681630	6	0.666666666666667	NA	NA	NA			28			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL13A1&recr=Open">Click here</a>	
COL13A1	Intron		C	C		11	Filtered Calls	10	71681631	71681631	6	0.666666666666667	NA	NA	NA			28			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL13A1&recr=Open">Click here</a>	
COL3A1	Silent	p.P236P	C	C		11	Filtered Calls	2	189854839	189854839	153	0.320261437908497	NA	NA	NA			126	Triple-helical region.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL3A1&recr=Open">Click here</a>	
CPT1A	5'UTR		C	C		11	Filtered Calls	11	68566698	68566698	58	0.258620689655172	NA	NA	NA			42			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPT1A&recr=Open">Click here</a>	
DHX40	Intron		C	C		11	Filtered Calls	17	57643976	57643976	68	0.338235294117647	NA	NA	NA			20			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHX40&recr=Open">Click here</a>	
DMRTC2	Intron		G	G		11	Filtered Calls	19	42354452	42354452	151	0.423841059602649	NA	NA	NA			10			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMRTC2&recr=Open">Click here</a>	
DRD3	Silent	p.P135P	G	G	rs199529083	11	Filtered Calls	3	113866383	113866383	135	0.296296296296296	NA	NA	NA			36			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DRD3&recr=Open">Click here</a>	
FAM98A	Intron		G	G	rs370217320	11	Filtered Calls	2	33810523	33810523	85	0.458823529411765	NA	NA	NA			24			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM98A&recr=Open">Click here</a>	
FRMD8	Intron		C	C		11	Filtered Calls	11	65154600	65154600	82	0.463414634146341	NA	NA	NA			17			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMD8&recr=Open">Click here</a>	
GRIN2B	Intron		C	C	rs201242368	11	Filtered Calls	12	13768038	13768038	207	0.338164251207729	NA	NA	NA			143			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2B&recr=Open">Click here</a>	
GTF3C4	Silent	p.N499N	C	C		11	Filtered Calls	9	135554503	135554503	295	0.0135593220338983	NA	NA	NA			20			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTF3C4&recr=Open">Click here</a>	
HHLA2	Silent	p.D115D	C	C	rs371274078	11	Filtered Calls	3	108072554	108072554	142	0.0422535211267606	NA	NA	NA			18	Ig-like V-type 1.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HHLA2&recr=Open">Click here</a>	
HINT3	Silent	p.S167S	C	C		11	Filtered Calls	6	126296104	126296104	180	0.522222222222222	NA	NA	NA			4			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HINT3&recr=Open">Click here</a>	
HIRA	Silent	p.L657L	G	G		11	Filtered Calls	22	19349261	19349261	155	0.283870967741935	NA	NA	NA			37	Interaction with CCNA1.|Interaction with PAX3. {ECO:0000250}.|Interaction with histone H2B.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIRA&recr=Open">Click here</a>	
HNF4G	Silent	p.K95K	G	G		11	Filtered Calls	8	76459849	76459849	619	0.294022617124394	NA	NA	NA			37			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HNF4G&recr=Open">Click here</a>	
HSD11B1	Silent	p.L190L	G	G		11	Filtered Calls	1	209905833	209905833	487	0.427104722792608	NA	NA	NA			16			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD11B1&recr=Open">Click here</a>	
KCNAB1	Intron		C	C	rs371371064	11	Filtered Calls	3	156177607	156177607	269	0.304832713754647	NA	NA	NA			28			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNAB1&recr=Open">Click here</a>	
KLHL2	Intron		-	-		11	Filtered Calls	4	166160105	166160106	149	0.516778523489933	NA	NA	NA			14			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL2&recr=Open">Click here</a>	
KLHL20	Intron		C	C		11	Filtered Calls	1	173702845	173702845	164	0.359756097560976	NA	NA	NA			34			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL20&recr=Open">Click here</a>	
LRP1B	Silent	p.E2464E	T	T		11	Filtered Calls	2	141298663	141298663	287	0.421602787456446	NA	NA	NA			606	EGF-like 10. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	
LRP2	Silent	p.L3518L	G	G		11	Filtered Calls	2	170032940	170032940	113	0.274336283185841	NA	NA	NA			315	LDL-receptor class A 26. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	
LRRIQ4	Silent	p.I262I	C	C		11	Filtered Calls	3	169540495	169540495	43	0.27906976744186	NA	NA	NA			30			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ4&recr=Open">Click here</a>	
MAP4K2	Intron		G	G		11	Filtered Calls	11	64564499	64564499	17	0.411764705882353	NA	NA	NA			8			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP4K2&recr=Open">Click here</a>	
MROH2B	Silent	p.I808I	G	G	rs546133595	11	Filtered Calls	5	41032861	41032861	72	0.347222222222222	NA	NA	NA		p.I808I(1)	NA			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	
MROH2B	Silent	p.K779K	C	C		11	Filtered Calls	5	41033167	41033167	117	0.307692307692308	NA	NA	NA			NA			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	
MYO1G	Silent	p.I396I	G	G		11	Filtered Calls	7	45010220	45010220	40	0.2	NA	NA	NA			28	Myosin motor.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1G&recr=Open">Click here</a>	
NEB	Silent	p.F2357F	G	G		11	Filtered Calls	2	152507244	152507244	1067	0.393626991565136	NA	NA	NA			301			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	
NEK4	Silent	p.R47R	C	C		11	Filtered Calls	3	52802573	52802573	336	0.0148809523809524	NA	NA	NA			26	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEK4&recr=Open">Click here</a>	
NLRP11	Silent	p.I738I	G	G		11	Filtered Calls	19	56307574	56307574	184	0.391304347826087	NA	NA	NA			66			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP11&recr=Open">Click here</a>	
NRDE2	Silent	p.D559D	G	G		11	Filtered Calls	14	90759206	90759206	207	0.0193236714975845	NA	NA	NA			NA			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRDE2&recr=Open">Click here</a>	
NRK	Silent	p.L669L	C	C		11	Filtered Calls	X	105153638	105153638	21	0.666666666666667	NA	NA	NA			76			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRK&recr=Open">Click here</a>	
OR10G8	Silent	p.F163F	C	C		11	Filtered Calls	11	123900818	123900818	252	0.261904761904762	NA	NA	NA			44			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10G8&recr=Open">Click here</a>	
OR13C3	Silent	p.F207F	G	G		11	Filtered Calls	9	107298474	107298474	329	0.319148936170213	NA	NA	NA			19			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR13C3&recr=Open">Click here</a>	
OR2M4	Silent	p.T23T	C	C		11	Filtered Calls	1	248402299	248402299	340	0.291176470588235	NA	NA	NA			50			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2M4&recr=Open">Click here</a>	
OR4Q3	Silent	p.L15L	G	G		11	Filtered Calls	14	20215631	20215631	450	0.288888888888889	NA	NA	NA			47			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4Q3&recr=Open">Click here</a>	
OR5I1	Silent	p.L200L	G	G		11	Filtered Calls	11	55703277	55703277	88	0.318181818181818	NA	NA	NA			52			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5I1&recr=Open">Click here</a>	
PEG3	Silent	p.I86I	G	G		11	Filtered Calls	19	57335766	57335766	161	0.298136645962733	NA	NA	NA			170	SCAN box. {ECO:0000255|PROSITE- ProRule:PRU00187}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEG3&recr=Open">Click here</a>	
PLCH1	Silent	p.S848S	G	G		11	Filtered Calls	3	155205856	155205856	171	0.298245614035088	NA	NA	NA			107			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCH1&recr=Open">Click here</a>	
PPP1R32	Silent	p.I199I	C	C		11	Filtered Calls	11	61253293	61253293	60	0.233333333333333	NA	NA	NA			NA			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R32&recr=Open">Click here</a>	
PRIMPOL	Silent	p.Y146Y	C	C	rs201667994	11	Filtered Calls	4	185587100	185587100	201	0.0199004975124378	NA	NA	NA			NA			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRIMPOL&recr=Open">Click here</a>	
RABEP1	Intron		C	C		11	Filtered Calls	17	5211986	5211986	171	0.274853801169591	NA	NA	NA			8			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RABEP1&recr=Open">Click here</a>	
RBP2	Silent	p.E101E	C	C		11	Filtered Calls	3	139173622	139173622	231	0.372294372294372	NA	NA	NA			12			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBP2&recr=Open">Click here</a>	
REV3L	Silent	p.Y150Y	G	G		11	Filtered Calls	6	111726788	111726788	327	0.018348623853211	NA	NA	NA			88			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REV3L&recr=Open">Click here</a>	
RGS12	Intron		G	G	rs201389750	11	Filtered Calls	4	3416582	3416582	222	0.148648648648649	NA	NA	NA			43			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS12&recr=Open">Click here</a>	
SCMH1	Silent	p.T517T	G	G		11	Filtered Calls	1	41503131	41503131	185	0.0378378378378378	NA	NA	NA			15			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCMH1&recr=Open">Click here</a>	
SLC17A3	Intron		G	G		11	Filtered Calls	6	25849598	25849598	158	0.177215189873418	NA	NA	NA			20			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A3&recr=Open">Click here</a>	
SVEP1	Silent	p.N1452N	G	G	rs140985683	11	Filtered Calls	9	113208155	113208155	350	0.0114285714285714	NA	NA	NA		p.N1475N(1)	147	Pentaxin.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SVEP1&recr=Open">Click here</a>	
TEKT5	Intron		G	G		11	Filtered Calls	16	10721664	10721664	21	0.285714285714286	NA	NA	NA			34			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEKT5&recr=Open">Click here</a>	
TFEC	Silent	p.G51G	C	C		11	Filtered Calls	7	115624343	115624343	1602	0.641073657927591	NA	NA	NA			25	Necessary for transcriptional transactivation.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFEC&recr=Open">Click here</a>	
TMC1	Intron		C	C		11	Filtered Calls	9	75369695	75369695	110	0.363636363636364	NA	NA	NA			36			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC1&recr=Open">Click here</a>	
TNNC1	Silent	p.G91G	C	C		11	Filtered Calls	3	52485804	52485804	71	0.309859154929577	NA	NA	NA			6			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNNC1&recr=Open">Click here</a>	
TRIB3	Silent	p.V179V	C	C	rs377271355	11	Filtered Calls	20	372176	372176	28	0.214285714285714	NA	NA	NA			21	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIB3&recr=Open">Click here</a>	
ZNF467	Silent	p.A589A	C	C		11	Filtered Calls	7	149461824	149461824	30	0.1	NA	NA	NA			13			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF467&recr=Open">Click here</a>	
ZNF560	5'UTR		C	C		11	Filtered Calls	19	9585993	9585993	146	0.308219178082192	NA	NA	NA			65			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF560&recr=Open">Click here</a>	
ZNF608	Silent	p.K1176K	T	T		11	Filtered Calls	5	123982549	123982549	294	0.0680272108843537	NA	NA	NA			46			MEL-IPI_Pat129-Tumor-SM-5X2R7	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF608&recr=Open">Click here</a>	
